Somatic Symptom Disorder (DSM-V): Clinical Trials

2 trials for Somatic Symptom Disorder (DSM-V), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 41Recruiting 1

Follow Somatic Symptom Disorder (DSM-V): new trials by email Literature Review of Somatic Symptom Disorder (DSM-V) trials Research Report on Somatic Symptom Disorder (DSM-V)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder
Venlafaxine, Dosulepin - Somatic Symptom Disorder (DSM-V)
Phase 4RecruitingAll India Institute of Medical Sciences, Bhubaneswar842025-03-112025-09-24
Cognitive-Behavioral Therapy Enriched With Emotion Regulation Training for Multiple Somatoform Symptoms
Cognitive-behavioral therapy + emotion regulation training for patients with multiple somatoform symptoms, Cognitive-behavioral therapy for patients with multiple somatoform symptoms - Somatic Symptom Disorder (DSM-V)
Not applicableCompletedPhilipps University Marburg2552013-10-012017-08-11

Narrower conditions

Medically Unexplained Symptoms (1)  ·  Somatoform Disorders (1)

Broader conditions

Mental Disorders (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Cognitive Behavioral Therapy (1)  ·  Dothiepin (1)  ·  Venlafaxine Hydrochloride (1)

Sponsors

All India Institute of Medical Sciences, Bhubaneswar (1)  ·  Philipps University Marburg (1)

Countries

Germany (1)  ·  India (1)

Top investigators

Japhia-Maria Gottschalk, M.Sc. (1)  ·  Mathias Berking, Ph.D. (1)  ·  Winfried Rief, Ph.D. (1)

Results publications

PMID 26655432, PMID 28867416, PMID 34711141